The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 14, 2005

Filed:

Jan. 14, 2002
Applicants:

Zsuzsanna Lonovics, Taszar, HU;

Julius Gy. Papp, Szeged, HU;

Dirk Thormaehlen, Rheden, DE;

Harald Waldeck, Isernhagen, DE;

Inventors:

Zsuzsanna Lonovics, Taszar, HU;

Julius Gy. Papp, Szeged, HU;

Dirk Thormaehlen, Rheden, DE;

Harald Waldeck, Isernhagen, DE;

Assignee:

Solvay Pharmaceuticals, Hannover, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K031/55 ; A61K031/12 ;
U.S. Cl.
CPC ...
Abstract

The use of benzazepin-N-acetic acid derivatives which contain an oxo group in the a position to the nitrogen atom and are substituted in the 3 position by a 1-(carboxyalkyl)-cyclopentyl-carbonyl-amino radical, and of their salts and biolabile esters, for the prophylaxis and/or treatment of heart damage caused by cardiotoxic doses of medicaments or chemicals, in larger mammals and in particular humans. The invention is particularly applicable to the prophylaxis and/or treatment of heart damage, in particular to the myocardium, which may occur during cytostatic chemotherapy. The invention also includes the use of the afore-mentioned benzazepin-N-acetic acid derivatives for adjuvant treatment in therapies in which medicaments having oxidative-toxic side-effects are used, and the preparation of medicaments suitable for this prophylaxis and/or treatment or adjuvant treatment.


Find Patent Forward Citations

Loading…